List of Tables
Table 1. Global PDE5 Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global PDE5 Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global PDE5 Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global PDE5 Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global PDE5 Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global PDE5 Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global PDE5 Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market PDE5 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of PDE5 Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of PDE5 Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of PDE5 Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of PDE5 Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDE5 Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on PDE5 Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDE5 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global PDE5 Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global PDE5 Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global PDE5 Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global PDE5 Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global PDE5 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global PDE5 Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global PDE5 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global PDE5 Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America PDE5 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America PDE5 Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America PDE5 Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America PDE5 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America PDE5 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe PDE5 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe PDE5 Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe PDE5 Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe PDE5 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe PDE5 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific PDE5 Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific PDE5 Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific PDE5 Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific PDE5 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific PDE5 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America PDE5 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America PDE5 Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America PDE5 Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America PDE5 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America PDE5 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa PDE5 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa PDE5 Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa PDE5 Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa PDE5 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa PDE5 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global PDE5 Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global PDE5 Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global PDE5 Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global PDE5 Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global PDE5 Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global PDE5 Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global PDE5 Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global PDE5 Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global PDE5 Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global PDE5 Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global PDE5 Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global PDE5 Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global PDE5 Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global PDE5 Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global PDE5 Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global PDE5 Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global PDE5 Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global PDE5 Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global PDE5 Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global PDE5 Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer PDE5 Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly PDE5 Inhibitors Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Metuchen Pharmaceuticals Company Information
Table 81. Metuchen Pharmaceuticals Description and Business Overview
Table 82. Metuchen Pharmaceuticals PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Metuchen Pharmaceuticals PDE5 Inhibitors Product
Table 84. Metuchen Pharmaceuticals Recent Developments/Updates
Table 85. SK Chemicals Life Science Company Information
Table 86. SK Chemicals Life Science Description and Business Overview
Table 87. SK Chemicals Life Science PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. SK Chemicals Life Science PDE5 Inhibitors Product
Table 89. SK Chemicals Life Science Recent Developments/Updates
Table 90. Dong-A Pharmaceutical Company Information
Table 91. Dong-A Pharmaceutical Description and Business Overview
Table 92. Dong-A Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Dong-A Pharmaceutical PDE5 Inhibitors Product
Table 94. Dong-A Pharmaceutical Recent Developments/Updates
Table 95. Cristália Company Information
Table 96. Cristália Description and Business Overview
Table 97. Cristália PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cristália PDE5 Inhibitors Product
Table 99. Cristália Recent Developments/Updates
Table 100. Hetero Company Information
Table 101. Hetero Description and Business Overview
Table 102. Hetero PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Hetero PDE5 Inhibitors Product
Table 104. Hetero Recent Developments/Updates
Table 105. Teva Company Information
Table 106. Teva Description and Business Overview
Table 107. Teva PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Teva PDE5 Inhibitors Product
Table 109. Teva Recent Developments/Updates
Table 110. Aurobindo Pharma Company Information
Table 111. Aurobindo Pharma Description and Business Overview
Table 112. Aurobindo Pharma PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Aurobindo Pharma PDE5 Inhibitors Product
Table 114. Aurobindo Pharma Recent Developments/Updates
Table 115. Watson Laboratories Company Information
Table 116. Watson Laboratories Description and Business Overview
Table 117. Watson Laboratories PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Watson Laboratories PDE5 Inhibitors Product
Table 119. Watson Laboratories Recent Developments/Updates
Table 120. Cipla Company Information
Table 121. Cipla Description and Business Overview
Table 122. Cipla PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Cipla PDE5 Inhibitors Product
Table 124. Cipla Recent Developments/Updates
Table 125. Sun Pharma Company Information
Table 126. Sun Pharma Description and Business Overview
Table 127. Sun Pharma PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sun Pharma PDE5 Inhibitors Product
Table 129. Sun Pharma Recent Developments/Updates
Table 130. Lupin Company Information
Table 131. Lupin Description and Business Overview
Table 132. Lupin PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lupin PDE5 Inhibitors Product
Table 134. Lupin Recent Developments/Updates
Table 135. MSN Company Information
Table 136. MSN Description and Business Overview
Table 137. MSN PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. MSN PDE5 Inhibitors Product
Table 139. MSN Recent Developments/Updates
Table 140. Zydus Company Information
Table 141. Zydus Description and Business Overview
Table 142. Zydus PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Zydus PDE5 Inhibitors Product
Table 144. Zydus Recent Developments/Updates
Table 145. Alkem Company Information
Table 146. Alkem Description and Business Overview
Table 147. Alkem PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Alkem PDE5 Inhibitors Product
Table 149. Alkem Recent Developments/Updates
Table 150. Amneal Pharmaceuticals Company Information
Table 151. Amneal Pharmaceuticals Description and Business Overview
Table 152. Amneal Pharmaceuticals PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Amneal Pharmaceuticals PDE5 Inhibitors Product
Table 154. Amneal Pharmaceuticals Recent Developments/Updates
Table 155. Dr. Reddy's Laboratories Company Information
Table 156. Dr. Reddy's Laboratories Description and Business Overview
Table 157. Dr. Reddy's Laboratories PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Dr. Reddy's Laboratories PDE5 Inhibitors Product
Table 159. Dr. Reddy's Laboratories Recent Developments/Updates
Table 160. Chartwell Company Information
Table 161. Chartwell Description and Business Overview
Table 162. Chartwell PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Chartwell PDE5 Inhibitors Product
Table 164. Chartwell Recent Developments/Updates
Table 165. Eugia Pharma Company Information
Table 166. Eugia Pharma Description and Business Overview
Table 167. Eugia Pharma PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Eugia Pharma PDE5 Inhibitors Product
Table 169. Eugia Pharma Recent Developments/Updates
Table 170. Qilu Pharmaceutical Company Information
Table 171. Qilu Pharmaceutical Description and Business Overview
Table 172. Qilu Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Qilu Pharmaceutical PDE5 Inhibitors Product
Table 174. Qilu Pharmaceutical Recent Developments/Updates
Table 175. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 176. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 177. Guangzhou Baiyunshan Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Guangzhou Baiyunshan Pharmaceutical PDE5 Inhibitors Product
Table 179. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 180. Yangtze River Pharmaceutical Company Information
Table 181. Yangtze River Pharmaceutical Description and Business Overview
Table 182. Yangtze River Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Yangtze River Pharmaceutical PDE5 Inhibitors Product
Table 184. Yangtze River Pharmaceutical Recent Developments/Updates
Table 185. Sichuan Kelun Pharmaceutical Company Information
Table 186. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 187. Sichuan Kelun Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. Sichuan Kelun Pharmaceutical PDE5 Inhibitors Product
Table 189. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 190. Regenex Pharmaceutical Company Information
Table 191. Regenex Pharmaceutical Description and Business Overview
Table 192. Regenex Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Regenex Pharmaceutical PDE5 Inhibitors Product
Table 194. Regenex Pharmaceutical Recent Developments/Updates
Table 195. Haisco Pharmaceutical Company Information
Table 196. Haisco Pharmaceutical Description and Business Overview
Table 197. Haisco Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 198. Haisco Pharmaceutical PDE5 Inhibitors Product
Table 199. Haisco Pharmaceutical Recent Developments/Updates
Table 200. Shanghai Huilun Pharmaceutical Company Information
Table 201. Shanghai Huilun Pharmaceutical Description and Business Overview
Table 202. Shanghai Huilun Pharmaceutical PDE5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 203. Shanghai Huilun Pharmaceutical PDE5 Inhibitors Product
Table 204. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. PDE5 Inhibitors Distributors List
Table 208. PDE5 Inhibitors Customers List
Table 209. PDE5 Inhibitors Market Trends
Table 210. PDE5 Inhibitors Market Drivers
Table 211. PDE5 Inhibitors Market Challenges
Table 212. PDE5 Inhibitors Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
Table 216. Authors List of This Report
List of Figures
Figure 1. Product Picture of PDE5 Inhibitors
Figure 2. Global PDE5 Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global PDE5 Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Sildenafil Product Picture
Figure 5. Tadalafil Product Picture
Figure 6. Vardenafil Product Picture
Figure 7. Avanafil Product Picture
Figure 8. Mirodenafil Product Picture
Figure 9. Udenafil Product Picture
Figure 10. Lodenafil Product Picture
Figure 11. Other Product Picture
Figure 12. Global PDE5 Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 13. Global PDE5 Inhibitors Market Share by Application: 2025 & 2032
Figure 14. Erectile Dysfunction (ED)
Figure 15. Pulmonary Hypertension
Figure 16. Reilly's Phenomena
Figure 17. Other
Figure 18. Global PDE5 Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global PDE5 Inhibitors Market Size (US$ Million), 2021–2032
Figure 20. Global PDE5 Inhibitors Sales (K Units), 2021–2032
Figure 21. Global PDE5 Inhibitors Average Price (US$/Unit), 2021–2032
Figure 22. PDE5 Inhibitors Report Years Considered
Figure 23. PDE5 Inhibitors Sales Share by Manufacturers in 2025
Figure 24. Global PDE5 Inhibitors Revenue Share by Manufacturers in 2025
Figure 25. Top 5 and Top 10 Global PDE5 Inhibitors Players: Market Share by Revenue in PDE5 Inhibitors in 2025
Figure 26. PDE5 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 27. Global PDE5 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 28. North America PDE5 Inhibitors Sales Market Share by Country (2021–2032)
Figure 29. North America PDE5 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 30. United States PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Canada PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Europe PDE5 Inhibitors Sales Market Share by Country (2021–2032)
Figure 33. Europe PDE5 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 34. Germany PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. France PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. U.K. PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Italy PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Russia PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Asia Pacific PDE5 Inhibitors Sales Market Share by Region (2021–2032)
Figure 40. Asia Pacific PDE5 Inhibitors Revenue Market Share by Region (2021–2032)
Figure 41. China PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Japan PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. South Korea PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. India PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Australia PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. China Taiwan PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Southeast Asia PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Latin America PDE5 Inhibitors Sales Market Share by Country (2021–2032)
Figure 49. Latin America PDE5 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 50. Mexico PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Brazil PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Argentina PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Colombia PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Middle East and Africa PDE5 Inhibitors Sales Market Share by Country (2021–2032)
Figure 55. Middle East and Africa PDE5 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 56. Turkey PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Saudi Arabia PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. UAE PDE5 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Global Sales Market Share of PDE5 Inhibitors by Type (2021–2032)
Figure 60. Global Revenue Market Share of PDE5 Inhibitors by Type (2021–2032)
Figure 61. Global PDE5 Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 62. Global Sales Market Share of PDE5 Inhibitors by Application (2021–2032)
Figure 63. Global Revenue Market Share of PDE5 Inhibitors by Application (2021–2032)
Figure 64. Global PDE5 Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 65. PDE5 Inhibitors Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
